DEM BioPharma

Pfizer-Backed DEM Bio Launches to Leverage CRISPR in Immuno-Oncology
BioSpace
Thu, 06/23/22 - 10:42 am
DEM BioPharma
CRISPR
immuno-oncology
Pfizer